Log in to save to my catalogue

Core Outcome Set development for LEPtospirosis trials (COS-LEP): a study protocol to develop a core...

Core Outcome Set development for LEPtospirosis trials (COS-LEP): a study protocol to develop a core...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_82a522b347f747a599fbf2a92177764e

Core Outcome Set development for LEPtospirosis trials (COS-LEP): a study protocol to develop a core outcome set for the evaluation of clinical therapeutic interventions for human leptospirosis

About this item

Full title

Core Outcome Set development for LEPtospirosis trials (COS-LEP): a study protocol to develop a core outcome set for the evaluation of clinical therapeutic interventions for human leptospirosis

Publisher

England: BioMed Central Ltd

Journal title

Current controlled trials in cardiovascular medicine, 2025-01, Vol.26 (1), p.6-9, Article 6

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Leptospirosis is a zoonotic bacterial infection occurring worldwide. It is of particular public health concern due to its global distribution, epidemic potential and high mortality without appropriate treatment. The method for the management of leptospirosis, particularly in severe disease, is clouded by methodological inconsistency and a lack of s...

Alternative Titles

Full title

Core Outcome Set development for LEPtospirosis trials (COS-LEP): a study protocol to develop a core outcome set for the evaluation of clinical therapeutic interventions for human leptospirosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_82a522b347f747a599fbf2a92177764e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_82a522b347f747a599fbf2a92177764e

Other Identifiers

ISSN

1745-6215

E-ISSN

1745-6215

DOI

10.1186/s13063-024-08713-6

How to access this item